Stock Alert: Compugen Up 10% As Loss Narrower Than Street View

Shares of Israeli drug development company Compugen Ltd. (CGEN) are up 10 percent on Thursday's trading as the company reported a first-quarter net loss lesser than analysts' expectations.

During the three-month period, Compugen reported net loss of $9.9 million or $0.12 per share, compared to net loss of $7.1 million or $0.10 per share in the same period last year.

On average, 7 analysts polled by Thomson Reuters expected the company to report net loss of $0.13 per share in the quarter. Analysts' estimates, usually, exclude one-time items.

The company's operating loss widened to $10.3 million in the first quarter from $7.39 million a year ago.

The stock was trading at $7.58, up $0.72 or 10 percent on the NYSE.

CGEN has traded between $6.74 and $19.90 during the 52-week range.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Follow RTT